HealthEquity (HQY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended October 2025 HealthEquity reported revenue of $322.16 million, up 7.2% year-over-year and modestly above the Zacks consensus of $319.96 million (+0.69% surprise), and EPS of $1.01 versus consensus $0.90 (+12.22% surprise). Key operating metrics showed asset growth — total HSA assets $34.45 billion (vs. $33.68B est.), HSA investments $17.54B (vs. $16.22B est.) — while revenue mix included Service $120.29M, Custodial $159.07M and Interchange $42.81M; custodial revenue rose ~12.9% YoY. The results indicate modest top-line growth with earnings leverage and stronger-than-expected asset/investment balances supporting fee revenue, which may reinforce investor interest despite a Zacks Rank #3 (Hold).

Analysis

Market structure: HealthEquity (HQY) is a direct beneficiary of secular HSA adoption and the quarter shows invested assets ($17.54bn) now exceeding cash ($16.91bn), which amplifies fee-with-assets revenue and gives HQY modest pricing power on custodial/asset fees. Winners include custodial/TPA providers and underlying asset managers; losers are low‑fee cash custodians and any rival with weaker investment take‑rates. Cross-asset: rising invested HSA balances modestly increase demand for equities/fixed income; a sharp market drop would immediately depress HQY revenue via AUM sensitivity and widen option-implied vol for HQY stock.

Risk assessment: Key tail risks are adverse tax/legislative changes to HSA rules, a >15% market correction wiping out invested balances, or a major cyber/breach impacting client retention. Immediate (days): muted trading around a +0.7% revenue beat; short term (3–6 months): flows and custodial fee cadence matter; long term (12–24 months): secular adoption and fee expansion drive multiple re-rating. Hidden dependency: custodial revenue is levered to asset returns and employer plan renewals; watch quarterly custodial growth as a leading indicator.

Trade implications: Establish a tactical long in HQY (2–3% portfolio) with defined risk: buy a 6‑month 10% OTM call spread (target +15–25% upside) or buy stock with a 6–9 month protective put (10% OTM). Pair trade: long HQY vs short UNH (equal dollar, hedge ~50% beta) to isolate HSA-specific growth vs insurer exposure over 3–6 months. If volatility rises, sell 30–45 day OTM puts to collect premium sized to target entry.

Key Decisions for Investors

• Establish a 2–3% long position in HQY: buy shares now or accumulate via a 6‑month 10% OTM call spread (buy 10% OTM call, sell 25% OTM call) sized to equal a 2–3% portfolio notional; target +20% price gain, take profits at +20% or if custodial revenue growth falls below +5% y/y next quarter.
• Implement a hedged stock trade: buy HQY and purchase a 6–9 month protective put at ~10% OTM sized to limit downside to ~8–10% of position value; reduce position if Total HSA Assets decline >5% QoQ or HSA investments decline >7% QoQ.
• Pair trade (relative value): go long HQY and short UNH (equal dollar, hedge ~50% beta) for 3–6 months to capture HSA asset-growth alpha while hedging broad healthcare/insurer exposure; unwind if HQY/UNH spread moves unfavorably by >8% or if macro equity market drops >10%.
• Sell short-dated (30–45 day) OTM puts on HQY to collect premium if implied vol spikes; size premium to target a net entry price no higher than 5% above current share price and avoid assignment if HQY falls >12%.
• Monitor legislative/tax calendar and earnings cadence: if any proposed HSA rule change appears in the next 60 days (Congress or Treasury guidance), reduce net long exposure by 50% immediately; conversely, increase exposure if AUM growth sustains >8% y/y for two consecutive quarters.